Evidence map›Paper›PMID 30760708›Full record

ArticleNature communications2019

tmem33 is essential for VEGF-mediated endothelial calcium oscillations and angiogenesis.

Aaron M Savage, Sathishkumar Kurusamy, Yan Chen, Zhen Jiang, Karishma Chhabria, Ryan B MacDonald, Hyejeong R Kim, Heather L Wilson, Fredericus J M van Eeden, Angel L Armesilla and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Article
  3. TMEM33 deletion potentiates anti-tumor CD8bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. VEGF signaling: Role in angiogenesis and beyond.Biochimica et biophysica acta. Reviews on cancer · 2024
    Review
  14. Cracking the Endothelial Calcium (CaInternational journal of molecular sciences · 2023
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Transient Receptor Potential (TRP) Channels in Tumor Vascularization.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Aaron M SavageDepartment of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield, UK.
Sathishkumar KurusamyCardiovascular Molecular Pharmacology Laboratory, Faculty of Science and Engineering, Research Institute in Healthcare Science, School of Pharmacy, University of Wolverhampton, Wolverhampton, UK.
Yan ChenDepartment of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield, UK.
Zhen JiangDepartment of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield, UK.
Karishma ChhabriaDepartment of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield, UK.
Ryan B MacDonaldDepartment of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield, UK.
Hyejeong R KimThe Bateson Centre, University of Sheffield, Sheffield, UK.
Heather L WilsonDepartment of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield, UK.
Fredericus J M van EedenThe Bateson Centre, University of Sheffield, Sheffield, UK.
Angel L ArmesillaCardiovascular Molecular Pharmacology Laboratory, Faculty of Science and Engineering, Research Institute in Healthcare Science, School of Pharmacy, University of Wolverhampton, Wolverhampton, UK.
Timothy J A ChicoDepartment of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield, UK.
Robert N WilkinsonDepartment of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield, UK. Robert.wilkinson@sheffield.ac.uk.ORCID http://orcid.org/0000-0003-2706-316X
University of Sheffield · GBUniversity of Wolverhampton · GB

Funding

British Heart Foundation PG/13/2/29902British Heart Foundation PG/15/17/31332National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/P001173/1
6 · The paper itself

Abstract

Angiogenesis requires co-ordination of multiple signalling inputs to regulate the behaviour of endothelial cells (ECs) as they form vascular networks. Vascular endothelial growth factor (VEGF) is essential for angiogenesis and induces downstream signalling pathways including increased cytosolic calcium levels. Here we show that transmembrane protein 33 (tmem33), which has no known function in multicellular organisms, is essential to mediate effects of VEGF in both zebrafish and human ECs. We find that tmem33 localises to the endoplasmic reticulum in zebrafish ECs and is required for cytosolic calcium oscillations in response to Vegfa. tmem33-mediated endothelial calcium oscillations are critical for formation of endothelial tip cell filopodia and EC migration. Global or endothelial-cell-specific knockdown of tmem33 impairs multiple downstream effects of VEGF including ERK phosphorylation, Notch signalling and embryonic vascular development. These studies reveal a hitherto unsuspected role for tmem33 and calcium oscillations in the regulation of vascular development.

Indexed as

Calcium SignalingNeovascularization, PhysiologicAnimalsBlood VesselsEmbryo, NonmammalianEndoplasmic ReticulumEndothelial CellsExtracellular Signal-Regulated MAP KinasesGene Knockdown TechniquesHumansMembrane ProteinsPhosphorylationVascular Endothelial Growth FactorsZebrafishExtracellular Signal-Regulated MAP KinasesMembrane Proteinstransmembrane protein 33, humanVascular Endothelial Growth Factors

Identifiers

PMID30760708
PMCPMC6374405
OpenAlexW2912781730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.